Dec. 3—Biospace med, an orthopaedic imaging company, has closed its venture capital financing, raising $18 million U.S. (€12 million). NBGI Ventures of London and Credit Agricole Private Equity of Paris led the financing.
Edmond de Rothschild Investment Partners of Paris and UFG PE of Paris, current investors in the company, also have subscribed to the current round of financing, according the to Paris-based Biospace. Aelios Finance served as financial advisor to Biospace.
Biospace said it will use the most recent round of funding to expand the marketing of EOS ultra low dose 2D/3D Xray internationally.